Articles

Lechleiter: It’s morning at Eli Lilly

Lilly CEO John Lechleiter kicked off the company’s quarterly conference call with investors and analysts by declaring an end to the “unprecedented challenge” that Lilly lived through the past four years.

Read More

The tragedy of electronic medical records

The federal government has spent $27 billion—and hospital systems have spent even more—to roll out electronic medical records across the industry. But even advocates say the results have been “disappointing.”

Read More

Dow Agro’s Enlist weed killer cleared by EPA

Enlist Duo can be used in six states, with approval pending in another 10, the Environmental Protection Agency said Wednesday. Dow is counting on the system to help double earnings at Dow AgroSciences in five to seven years.

Read More

While Pence and Obama dance, these folks are waiting

The Hoosiers waiting for Gov. Mike Pence and President Obama to work out a deal to expand health coverage have median household incomes of less than $10,000, typically have no college education and are disproportionately minorities.

Read More

USDA approves new modified corn, soybean seeds

The farmers won't be able to take full advantage of the seeds until the EPA issues a second ruling allowing the use of weed killer Enlist. The EPA has said it will rule this fall on Indianapolis-based Dow AgroSciences' application to market the chemical.

Read More